Payer’s Place: Shantanu Agrawal, MD, MPHIL, Elevance Health
Elevance Health is finding ways to connect with the community in order to achieve better health equity.
Payer Insights Program Highlights How Payers and Tech Partners Are Thinking About AI, Health Equity, and the Consumer Experience
HLTH 2023 introduced a new program focused on technology trends for and perspectives from payers in a series of conversations around AI, health equity and healthcare innovation.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
Payer’s Place: Camille Harrison, GuideWell, Florida Blue
What does the future hold with AI and the healthcare ecosystem? Camille Harrison with GuideWell, Florida Blue joins the Payer's Place to share her thoughts.
Payer’s Place: Dawn Maroney, Alignment Health
CEO of Alignment Health joins the Payer's Place and details how the growth of Medicare Advantage will only help patients in the future.
Payer’s Place: Dr. Anil Singh, Highmark Health
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis
Pharmaceutical industry observers say CVS Health’s creation of Cordavis, a new biosimilar drugs company, is part of a strategy to make its move into this market as profitable as possible.
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Payer’s Place: Don Antonucci, Providence Health Plan
The CEO of Providence Health Plan visits the Payer's Place and addresses the future of payment models.
Amgen, FTC Settlement Allows $28B Horizon Acquisition to Move Forward
Amgen and the Federal Trade Commission are settling the lawsuit the regulator filed to block the pharmaceutical giant’s $28 billion Horizon Therapeutics acquisition. As part of the settlement, Amgen agrees not to “bundle” its products with Horizon’s drugs in negotiations with health plans.
Payer’s Place: Carrie Kincaid, Priority Health
Carrie Kincaid, Senior Vice President, Market Development at Priority Health discusses how Priority Health is addressing the gaps in rural healthcare.
Payer’s Place: Peter Long, Blue Shield of California
Peter Long of Blue Shield of California discusses how they focus on member experience and ways to improve their overall healthcare needs.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
From Bottlenecks to Breakthroughs: Using Technology to Transform Specialty Medication Access and Affordability
We need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior authorization, from real-time benefit checks to financial assistance — on a central platform powered by a business rules engine, automated workflows, and real-time analytics.
Payer’s Place: David Calabrese
OptumRx's Chief Clinical Officer shares his insights on the latest developments and trends he's seen in the healthcare industry.
Rigorous Data Are Key to Convince Payers, Investors in the World of Digital Therapeutics
Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.
Introducing Payer’s Place, a Video Interview Series Highlighting Healthcare Payer Executive Perspectives
The series, part of a content partnership between HLTH and MedCity News, will share insights from executives from both public and private payer organizations based on developments and trends they've seen in the healthcare industry and what keeps them up at night.
CMS Will Cover Approved Alzheimer’s Drugs, But It Still Wants More Evidence
Medicare will cover Alzheimer’s disease drugs granted traditional FDA approval, CMS announced. But the decision keeps the spirit of an earlier coverage determination, which called for the gathering of more evidence about the safety and efficacy of these therapies.